{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T22:53:32Z","timestamp":1785365612601,"version":"3.55.0"},"reference-count":39,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"accepted":{"date-parts":[[2023,8,3]]},"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n<jats:title>Background\/Aims<\/jats:title>\n<jats:p>The incidence of retinopathy of prematurity (ROP) is increasing and treatment options are expanding, often without accompanying safety data. We aimed to define a minimal, patient-centred data set that is feasible to collect in clinical practice and can be used collaboratively to track and compare outcomes of ROP treatment with a view to improving patient outcomes.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A multinational group of clinicians and a patient representative with expertise in ROP and registry development collaborated to develop a data set that focused on real-world parameters and outcomes that were patient centred, minimal and feasible to collect in routine clinical practice.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>For babies receiving ROP treatment, we recommend patient demographics, systemic comorbidities, ROP status, treatment details, ophthalmic and systemic complications of treatment, ophthalmic and neurodevelopmental outcomes at initial treatment, any episodes of retreatment and follow-up examinations in the short and long-term to be collected for use in ROP studies, registries and routine clinical practice.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>We recommend these parameters to be used in registries and future studies of ROP treatment, to reduce the variation seen in previous reports and allow meaningful assessments and comparisons. They form the basis of the EU-ROP and the Fight Childhood Blindness! ROP Registries.<\/jats:p>\n<\/jats:sec>","DOI":"10.1136\/bjo-2023-323915","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T17:20:14Z","timestamp":1694625614000},"page":"1030-1037","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Development of a joint set of database parameters for the EU-ROP and Fight Childhood Blindness! ROP Registries"],"prefix":"10.1136","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7814-5902","authenticated-orcid":false,"given":"Caroline","family":"Catt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M","family":"Pfeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Barthelmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen A","family":"Gole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim U","family":"Krohne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3760-7255","authenticated-orcid":false,"given":"Wei-Chi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8364-0948","authenticated-orcid":false,"given":"Shunji","family":"Kusaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5092-9550","authenticated-orcid":false,"given":"Peiquan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Elder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Heckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Stack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gigi","family":"Khonyongwa-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,9,13]]},"reference":[{"issue":"Suppl 1","key":"2024062002150804000_108.7.1030.1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of Prematurity at regional and global levels for 2010","volume":"74 Suppl 1","author":"Blencowe","year":"2013","journal-title":"Pediatr Res"},{"key":"2024062002150804000_108.7.1030.2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.4.615"},{"key":"2024062002150804000_108.7.1030.3","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/APO.0000000000000313","article-title":"Retinopathy of Prematurity: how to prevent the third epidemics in developing countries","volume":"9","author":"Azad","year":"2020","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"2024062002150804000_108.7.1030.4","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1111\/apa.15197","article-title":"Higher incidence of retinopathy of Prematurity in extremely Preterm infants associated with improved survival rates","volume":"109","author":"Taner","year":"2020","journal-title":"Acta Paediatr"},{"key":"2024062002150804000_108.7.1030.5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/09286586.2019.1585885","article-title":"Retinopathy of Prematurity in Africa: a systematic review","volume":"26","author":"Wang","year":"2019","journal-title":"Ophthalmic Epidemiol"},{"key":"2024062002150804000_108.7.1030.6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1542\/peds.81.5.697","article-title":"Multicenter trial of Cryotherapy for retinopathy of Prematurity: preliminary results","volume":"81","year":"1988","journal-title":"Pediatrics"},{"key":"2024062002150804000_108.7.1030.7","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.12.1684"},{"key":"2024062002150804000_108.7.1030.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007374"},{"key":"2024062002150804000_108.7.1030.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31344-3"},{"key":"2024062002150804000_108.7.1030.10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1001\/jama.2022.10564","article-title":"Effect of intravitreal Aflibercept vs laser Photocoagulation on treatment success of retinopathy of Prematurity: the FIREFLEYE randomized clinical trial","volume":"328","author":"Stahl","year":"2022","journal-title":"JAMA"},{"key":"2024062002150804000_108.7.1030.11","article-title":"Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of Prematurity","volume":"1","author":"Sankar","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2024062002150804000_108.7.1030.12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1053\/j.semperi.2019.05.012","article-title":"Retinopathy of Prematurity, visual and neurodevelopmental outcome, and imaging of the central nervous system","volume":"43","author":"Morken","year":"2019","journal-title":"Semin Perinatol"},{"key":"2024062002150804000_108.7.1030.13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000487847","article-title":"Relation of retinopathy of Prematurity to brain volumes at term equivalent age and developmental outcome at 2 years of corrected age in very Preterm infants","volume":"114","author":"Sveinsd\u00f3ttir","year":"2018","journal-title":"Neonatology"},{"key":"2024062002150804000_108.7.1030.14","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.233"},{"key":"2024062002150804000_108.7.1030.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsb1609216"},{"key":"2024062002150804000_108.7.1030.16","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.ophtha.2021.05.031","article-title":"International classification of retinopathy of Prematurity","volume":"128","author":"Chiang","year":"2021","journal-title":"Ophthalmology"},{"key":"2024062002150804000_108.7.1030.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2018.04.002"},{"key":"2024062002150804000_108.7.1030.18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/apa.12799","article-title":"Prethreshold retinopathy in premature infants with Intrauterine growth restriction","volume":"104","author":"Lee","year":"2015","journal-title":"Acta Paediatr"},{"key":"2024062002150804000_108.7.1030.19","doi-asserted-by":"crossref","unstructured":"O\u2019Driscoll DN , McGovern M , Greene CM , et al . Gender disparities in Preterm neonatal outcomes. Acta Paediatr 11, 2018. doi:10.1111\/apa.14390","DOI":"10.1111\/apa.14390"},{"key":"2024062002150804000_108.7.1030.20","doi-asserted-by":"publisher","DOI":"10.1067\/mpa.2000.110342"},{"key":"2024062002150804000_108.7.1030.21","doi-asserted-by":"publisher","DOI":"10.1067\/S0022-3476(03)00243-9"},{"key":"2024062002150804000_108.7.1030.22","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/jamaophthalmol.2014.5185","article-title":"Predictors for the development of referral-warranted retinopathy of Prematurity in the Telemedicine approaches to evaluating acute-phase retinopathy of Prematurity (E-ROP) study","volume":"133","author":"Ying","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"2024062002150804000_108.7.1030.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2006.05.007"},{"key":"2024062002150804000_108.7.1030.24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.5725"},{"key":"2024062002150804000_108.7.1030.25","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/s41372-019-0357-2","article-title":"Prenatal and postnatal inflammation-related risk factors for retinopathy of Prematurity","volume":"39","author":"Goldstein","year":"2019","journal-title":"J Perinatol"},{"key":"2024062002150804000_108.7.1030.26","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-0944"},{"key":"2024062002150804000_108.7.1030.27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223427","article-title":"Impact of peri-intraventricular haemorrhage and periventricular leukomalacia in the Neurodevelopment of Preterms: A systematic review and meta-analysis","volume":"14","author":"Gotardo","year":"2019","journal-title":"PLoS One"},{"key":"2024062002150804000_108.7.1030.28","doi-asserted-by":"publisher","DOI":"10.1111\/pan.12310"},{"key":"2024062002150804000_108.7.1030.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2004.03.003"},{"key":"2024062002150804000_108.7.1030.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.04.028"},{"key":"2024062002150804000_108.7.1030.31","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.119.8.1110"},{"key":"2024062002150804000_108.7.1030.32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3928\/23258160-20190605-01","article-title":"Neurodevelopmental outcomes comparing Bevacizumab to laser for type 1 ROP","volume":"50","author":"Rodriguez","year":"2019","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"2024062002150804000_108.7.1030.33","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-305913"},{"key":"2024062002150804000_108.7.1030.34","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e318275394a"},{"key":"2024062002150804000_108.7.1030.35","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2014.941070"},{"key":"2024062002150804000_108.7.1030.36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148019","article-title":"Neurodevelopmental outcomes in infants with retinopathy of Prematurity and Bevacizumab treatment","volume":"11","author":"Lien","year":"2016","journal-title":"PLoS One"},{"key":"2024062002150804000_108.7.1030.37","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3218","article-title":"Neurodevelopmental outcomes following Bevacizumab injections for retinopathy of Prematurity","volume":"137","author":"Morin","year":"2016","journal-title":"Pediatrics"},{"key":"2024062002150804000_108.7.1030.38","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2012.2357"},{"key":"2024062002150804000_108.7.1030.39","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00347-018-0701-5","article-title":"Treated cases of retinopathy of Prematurity in Germany: 5-year data from the Retina.Net ROP Registry","volume":"115","author":"Walz","year":"2018","journal-title":"Ophthalmologe"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjo-2023-323915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T18:28:57Z","timestamp":1718908137000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjo-2023-323915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,13]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,6,20]]},"published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1136\/bjo-2023-323915"],"URL":"https:\/\/doi.org\/10.1136\/bjo-2023-323915","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,13]]}}}